These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28615138)

  • 21. Repeated liver resection for recurrent hepatocellular carcinoma.
    Faber W; Seehofer D; Neuhaus P; Stockmann M; Denecke T; Kalmuk S; Warnick P; Bahra M
    J Gastroenterol Hepatol; 2011 Jul; 26(7):1189-94. PubMed ID: 21410751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes and recurrence of initially resectable hepatocellular carcinoma meeting milan criteria: Rationale for partial hepatectomy as first strategy.
    Tanaka S; Noguchi N; Ochiai T; Kudo A; Nakamura N; Ito K; Kawamura T; Teramoto K; Arii S
    J Am Coll Surg; 2007 Jan; 204(1):1-6. PubMed ID: 17189106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MRI-based preoperative markers combined with narrow-margin hepatectomy result in higher early recurrence.
    Zuo L; Shi S; Fan J; Tian Z; Yu D
    Eur J Radiol; 2022 Dec; 157():110521. PubMed ID: 36274362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytopathologic evaluation of the in situ margin in patients undergoing hepatectomy.
    Jones NB; Wakely PE; Klemanski DL; Al-Saif O; Young G; Frankel WL; Martin EW; Bloomston M
    Cancer Cytopathol; 2012 Dec; 120(6):410-5. PubMed ID: 22605571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic resection for hepatocellular carcinoma in severely cirrhotic livers.
    Kaibori M; Matsui Y; Kitade H; Kwon AH; Kamiyama Y
    Hepatogastroenterology; 2003; 50(50):491-6. PubMed ID: 12749254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The meaning of gross tumor type in the aspects of cytokeratin 19 expression and resection margin in patients with hepatocellular carcinoma.
    Gong SC; Cho MY; Lee SW; Kim SH; Kim MY; Baik SK
    J Gastroenterol Hepatol; 2016 Jan; 31(1):206-12. PubMed ID: 26212571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Adjuvant Radiation Therapy With Long-Term Overall and Recurrence-Free Survival After Hepatectomy for Hepatocellular Carcinoma: A Multicenter Propensity-Matched Study.
    Gou XX; Shi HY; Li C; Chen ZL; Ouyang W; Sun LY; Diao YK; Wang MD; Yao LQ; Gu LH; Pawlik TM; Lau WY; Shen F; Xue J; Yang T
    Int J Radiat Oncol Biol Phys; 2022 Oct; 114(2):238-249. PubMed ID: 35643251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognosis of patients with intrahepatic recurrence after hepatic resection for hepatocellular carcinoma: a retrospective study.
    Kawano Y; Sasaki A; Kai S; Endo Y; Iwaki K; Uchida H; Shibata K; Ohta M; Kitano S
    Eur J Surg Oncol; 2009 Feb; 35(2):174-9. PubMed ID: 18325724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical significance of macroscopic no-margin hepatectomy for hepatocellular carcinoma.
    Oguro S; Yoshimoto J; Imamura H; Ishizaki Y; Kawasaki S
    HPB (Oxford); 2018 Sep; 20(9):872-880. PubMed ID: 29699859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anatomic versus limited nonanatomic resection for solitary hepatocellular carcinoma.
    Tanaka K; Shimada H; Matsumoto C; Matsuo K; Nagano Y; Endo I; Togo S
    Surgery; 2008 May; 143(5):607-15. PubMed ID: 18436008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective, single-center cohort study analyzing the efficacy of complete laparoscopic resection on recurrent hepatocellular carcinoma.
    Zhang J; Zhou ZG; Huang ZX; Yang KL; Chen JC; Chen JB; Xu L; Chen MS; Zhang YJ
    Chin J Cancer; 2016 Mar; 35():25. PubMed ID: 26956022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postoperative outcomes in patients with hepatocellular carcinomas resected with exposure of the tumor surface: clinical role of the no-margin resection.
    Matsui Y; Terakawa N; Satoi S; Kaibori M; Kitade H; Takai S; Kwon AH; Kamiyama Y
    Arch Surg; 2007 Jul; 142(7):596-602; discussion 603. PubMed ID: 17638795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome after partial hepatectomy for hepatocellular cancer within the Milan criteria.
    Fan ST; Poon RT; Yeung C; Lam CM; Lo CM; Yuen WK; Ng KK; Liu CL; Chan SC
    Br J Surg; 2011 Sep; 98(9):1292-300. PubMed ID: 21656513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgical margin and recurrence after resection of hepatocellular carcinoma in patients with cirrhosis. Further evaluation of limited hepatic resection.
    Yoshida Y; Kanematsu T; Matsumata T; Takenaka K; Sugimachi K
    Ann Surg; 1989 Mar; 209(3):297-301. PubMed ID: 2538106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic resection with and without surgical margins for hepatocellular carcinoma in patients with impaired liver function.
    Ochiai T; Takayama T; Inoue K; Yamamoto J; Shimada K; Kosuge T; Yamazaki S; Makuuchi M
    Hepatogastroenterology; 1999; 46(27):1885-9. PubMed ID: 10430364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of marginal resection for hepatocellular carcinoma.
    Kobayashi N; Aramaki O; Midorikawa Y; Higaki T; Nakayama H; Moriguchi M; Takayama T
    Surg Today; 2020 Nov; 50(11):1471-1479. PubMed ID: 32472316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significance of anatomical resection and resection margin status in patients with HBV-related hepatocellular carcinoma and microvascular invasion: a multicenter propensity score-matched study.
    Zhang XP; Xu S; Lin ZY; Gao QL; Wang K; Chen ZL; Yan ML; Zhang F; Tang YF; Zhao ZM; Li CG; Lau WY; Cheng SQ; Hu MG; Liu R
    Int J Surg; 2023 Apr; 109(4):679-688. PubMed ID: 36917129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors and patterns of recurrence after resection of hepatocellular carcinoma.
    Cha C; Fong Y; Jarnagin WR; Blumgart LH; DeMatteo RP
    J Am Coll Surg; 2003 Nov; 197(5):753-8. PubMed ID: 14585409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of recurrence in a long-term follow-up after surgery in 417 patients with hepatitis B- or hepatitis C-related hepatocellular carcinoma.
    Sasaki Y; Yamada T; Tanaka H; Ohigashi H; Eguchi H; Yano M; Ishikawa O; Imaoka S
    Ann Surg; 2006 Nov; 244(5):771-80. PubMed ID: 17060771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiofrequency ablation using a 10-mm target margin for small hepatocellular carcinoma in patients with liver cirrhosis: A prospective randomized trial.
    Liao M; Zhong X; Zhang J; Liu Y; Zhu Z; Wu H; Zeng Y; Huang J
    J Surg Oncol; 2017 Jun; 115(8):971-979. PubMed ID: 28334430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.